all report title image
  • Published In : Oct 2023
  • Code : CMI4305
  • Pages : 190
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical

The global spinal cord injury therapeutics market comprises therapeutics used for the treatment of spinal cord injury such as corticosteroids, non-steroidal anti-inflammatory drugs (NSAID’S), muscle relaxants, and anti-depressants. There are two types of spinal cord injuries including complete spinal cord injury and incomplete spinal cord injury and various causes of spinal cord injuries include brain injury, trauma, loss of blood supply to spinal cord, and compression in spinal cord due to tumor or infections.

Market Dynamics

Key players are focusing on product approvals to strengthen their position in the global spinal cord injury therapeutics market. For instance, in September 2020, AbbVie Inc., received an orphan drug and fast track designation from the U.S. Food and Drug Administration for Elezanumab, an investigational monoclonal antibody RGMa inhibitor for the treatment of spinal cord injury.

Key features of the study:

  • This report provides in-depth analysis of the global spinal cord injury therapeutics market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global spinal cord injury therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc., Pfizer Inc., Dr. Reddy's Laboratories Ltd., Zydus Cadila, ReNetX Bio, Inc., InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc., Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc., RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc., ScieGen Pharmaceuticals, Inc., MSN Laboratories Private Limited, and Lannett Co Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global spinal cord injury therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market

Detailed Segmentation:

  • Global Spinal Cord Injury Therapeutics Market, By Injury Type:
    • Complete Spinal Cord Injury
    • Incomplete Spinal Cord Injury
  • Global Spinal Cord Injury Therapeutics Market, By Drug Type:
    • Corticosteroids
    • Muscle Relaxants and Anti-spastic drugs
    • Non-steroidal Anti-inflammatory drugs (NSAIDs)
    • Anti-depressants
    • Anticonvulsants
    • Others
  • Global Spinal Cord Injury Therapeutics Market, By Application:
    • Autonomic Dysreflexia (AD)
    • Spasticity & Inflammation
    • Pain Management
    • Depression
  • Global Spinal Cord Injury Therapeutics Market, By Route of Administration:
    • Oral
    • Intravenous
  • Global Spinal Cord Injury Therapeutics Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Spinal Cord Injury Therapeutics Market, By Region:
    • North America
      • By Injury Type
        • Complete Spinal Cord Injury
        • Incomplete Spinal Cord Injury
      • By Drug Type
        • Corticosteroids
        • Muscle Relaxants and Anti-spastic drugs
        • Non-steroidal Anti-inflammatory drugs (NSAIDs)
        • Anti-depressants
        • Anticonvulsants
        • Others
      • By Application
        • Autonomic Dysreflexia (AD)
        • Spasticity & Inflammation
        • Pain Management
        • Depression
      • By Route of Administration
        • Oral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Injury Type
        • Complete Spinal Cord Injury
        • Incomplete Spinal Cord Injury
      • By Drug Type
        • Corticosteroids
        • Muscle Relaxants and Anti-spastic drugs
        • Non-steroidal Anti-inflammatory drugs (NSAIDs)
        • Anti-depressants
        • Anticonvulsants
        • Others
      • By Application
        • Autonomic Dysreflexia (AD)
        • Spasticity & Inflammation
        • Pain Management
        • Depression
      • By Route of Administration
        • Oral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Injury Type
        • Complete Spinal Cord Injury
        • Incomplete Spinal Cord Injury
      • By Drug Type
        • Corticosteroids
        • Muscle Relaxants and Anti-spastic drugs
        • Non-steroidal Anti-inflammatory drugs (NSAIDs)
        • Anti-depressants
        • Anticonvulsants
        • Others
      • By Application
        • Autonomic Dysreflexia (AD)
        • Spasticity & Inflammation
        • Pain Management
        • Depression
      • By Route of Administration
        • Oral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Injury Type
        • Complete Spinal Cord Injury
        • Incomplete Spinal Cord Injury
      • By Drug Type
        • Corticosteroids
        • Muscle Relaxants and Anti-spastic drugs
        • Non-steroidal Anti-inflammatory drugs (NSAIDs)
        • Anti-depressants
        • Anticonvulsants
        • Others
      • By Application
        • Autonomic Dysreflexia (AD)
        • Spasticity & Inflammation
        • Pain Management
        • Depression
      • By Route of Administration
        • Oral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Injury Type
        • Complete Spinal Cord Injury
        • Incomplete Spinal Cord Injury
      • By Drug Type
        • Corticosteroids
        • Muscle Relaxants and Anti-spastic drugs
        • Non-steroidal Anti-inflammatory drugs (NSAIDs)
        • Anti-depressants
        • Anticonvulsants
        • Others
      • By Application
        • Autonomic Dysreflexia (AD)
        • Spasticity & Inflammation
        • Pain Management
        • Depression
      • By Route of Administration
        • Oral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Injury Type
        • Complete Spinal Cord Injury
        • Incomplete Spinal Cord Injury
      • By Drug Type
        • Corticosteroids
        • Muscle Relaxants and Anti-spastic drugs
        • Non-steroidal Anti-inflammatory drugs (NSAIDs)
        • Anti-depressants
        • Anticonvulsants
        • Others
      • By Application
        • Autonomic Dysreflexia (AD)
        • Spasticity & Inflammation
        • Pain Management
        • Depression
      • By Route of Administration
        • Oral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • AbbVie Inc.
    • Pfizer Inc.
    • Reddy's Laboratories Ltd.
    • Zydus Cadila
    • ReNetX Bio, Inc.
    • InVivo Therapeutics Holdings
    • Lineage Cell Therapeutics, Inc.
    • Kringle Pharma, Inc.
    • Acorda Therapeutics, Inc.
    • Bioaxone Biosciences, Inc.
    • RespireRx Pharmaceuticals Inc.
    • NervGen
    • Rising Pharmaceuticals, Inc.
    • ScieGen Pharmaceuticals, Inc.
    • MSN Laboratories Private Limited
    • Lannett Co Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Indication
      • Market Snippet, By Application
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Spinal Cord Injury Therapeutics Market - COVID-19 Impact Analysis
    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand
  5. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Muscle Relaxants and Anti-spastic Drugs 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Non-steroidal Anti-inflammatory Drugs (NSAID’S)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Anti-depressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Anticonvulsants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  6. Global Spinal Cord Injury Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • Complete Spinal Cord Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Incomplete Spinal Cord Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  7. Global Spinal Cord Injury Therapeutics Market, By Application, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • Autonomic Dysreflexia (AD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Spasticity and Inflammation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Pain Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Depression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  10. Global Spinal Cord Injury Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region,  2018 - 2030, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  11. Competitive Landscape
    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Reddy's Laboratories Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Zydus Cadila
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • ReNetX Bio, Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • InVivo Therapeutics Holdings
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Lineage Cell Therapeutics, Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Kringle Pharma, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Acorda Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bioaxone Biosciences, Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • RespireRx Pharmaceuticals Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • NervGen
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Rising Pharmaceuticals, Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • ScieGen Pharmaceuticals, Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • MSN Laboratories Private Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Lannett Co Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Other Prominent Players
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  12. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 54 market data tables and 43 figures on “Global Spinal Cord Injury Therapeutics Market” - Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo